Skip to content
value.today
Cerecor Inc. logo

Cerecor Inc.

🇺🇸 Baltimore, Maryland, USABiotechnologyFounded 2011

Formerly Ceregen Inc.

Total raised
$45 M
3 rounds on record
Latest round
$16 M
Jul 2014
First round on record
Mar 2012
Today
Went public
See the company page

Cerecor Inc. is listed today as Avalo Therapeutics, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Cerecor Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$131 MPrivate placement after listing$50 to $250 million

Cerecor Inc.: Private sale, Mar 2024

Investors in this round

25 investors had bought by the notice of Apr 9, 2024: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$131 M of $200 M offered; $69 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$6,937,500
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher Sullivan · Executive Officer
  • Garry Neil, M.D. · Executive Officer, Director
  • Aaron Kantoff · Director
  • Gilla Kaplan, Ph.D. · Director
  • Jonathan Goldman, M.D. · Director
  • June Almenoff, M.D., Ph.D. · Director
  • Magnus Persson, M.D., Ph.D. · Director
  • Mitchell Chan · Director
  • Samantha Truex · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Oppenheimer & Co. Inc. (CRD 249) · New York, New YorkSold in all US states

Remarks in the notice

  • On the amounts: “The Total Remaining to be Sold represents warrants issued at closing that have not yet been exercised.”
  • On the use of proceeds: “Other than the payment of salaries and other compensation and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.”
  • On a merger: “The offering is made in connection with the merger of Project Athens Merger Sub, Inc. into AlmataBio, Inc. and AlmataBio, Inc. into Second Project Athens Merger Sub, LLC, pursuant to an Agreement and Plan of Merger and Reorganization dated March 27, 2024.”

Signed by Garry A. Neil, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

equity, optionsSEC
Apr 2017$5 MPrivate placement after listing$2 to $10 million

Cerecor Inc.: Private sale, Apr 2017

Investors in this round

1 investor had bought by the notice of May 8, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John E Kaiser · Executive Officer
  • Mariam E Morris · Executive Officer
  • Ronald E Marcus · Executive Officer
  • Uli Hacksell · Executive Officer, Director
  • Eugene A. Bauer · Director
  • Isaac A. Blech · Director
  • Magnus E Persson · Director
  • Phil E Gutry · Director
  • Thomas E Aasen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mariam E. Morris, Chief Financial Officer. Source: SEC Form D, newest notice filed May 8, 2017. Read the notice at the SEC.

optionsSEC
Sep 2016$1 MPrivate placement after listingUnder $2 million

Cerecor Inc.: Private sale, Sep 2016

Investors in this round

1 investor had bought by the notice of Sep 16, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $15 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Kaiser · Executive Officer
  • Mariam Morris · Executive Officer
  • Ronald Marcus · Executive Officer
  • Uli Hacksell · Executive Officer, Director
  • Behshad Sheldon · Director
  • Eugene Bauer · Director
  • Isaac Blech · Director
  • Magnus Persson · Director
  • Phil Gutry · Director
  • Thomas Aasen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mariam E. Morris, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 16, 2016. Read the notice at the SEC.

equitySEC
Jul 2014$16 MNo. 3$10 to $50 million

Cerecor Inc.: Raise no. 3, Jul 2014

Investors in this round

13 investors had bought by the notice of Jul 21, 2014: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$16 M of $33 M offered; $17 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Offer and sale of Series B Preferred Stock and Warrant to purchase shares of Common Stock, and underlying shares of Common Stock issuable upon conversion thereof
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$300,000
Paid to its own people
$755,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bernadine Heather Fraser · Executive Officer
  • Blake M. Paterson · Executive Officer, Director
  • Federica F. O'Brien · Executive Officer
  • James F. Vornov · Executive Officer
  • John F. Kaiser · Executive Officer
  • Reza F. Mazhari · Executive Officer
  • Sharon F. Rowland · Executive Officer
  • Eugene A. Bauer · Director
  • Frank A. Torti · Director
  • Isaac A. Blech · Director
  • Magnus A. Persson · Director
  • Mayukh A. Sukhatme · Director
  • Sol J. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Trout Capital LLC (CRD 131489) · New York, New YorkSold in MA, NJ, NY

Remarks in the notice

  • On fees: “3% of proceeds from certain investors”

Signed by Federica O'Brien, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 21, 2014. Read the notice at the SEC.

equity, debt, optionsSEC
Aug 2013$7 MNo. 2$2 to $10 million

Cerecor Inc.: Raise no. 2, Aug 2013

Investors in this round

146 investors had bought by the notice of Sep 6, 2013: 146 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $10 M offered; $3 M still to sell
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$555,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake M. Paterson · Executive Officer, Director
  • Federica F. O'Brien · Executive Officer
  • James F. Vornov · Executive Officer
  • John F. Kaiser · Executive Officer
  • Reza F. Mazhari · Executive Officer
  • Sharon F. Rowland · Executive Officer
  • Cary W. Sucoff, Jr. · Director
  • Eugene A. Bauer · Director
  • Isaac A. Blech · Director
  • John A. Catsimatidis · Director
  • Magnus A. Persson · Director
  • Sol F. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group, LLC (CRD 120708) · New York, New YorkSold in AK, AL, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV

Signed by Federica F. O'Brien, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 6, 2013. Read the notice at the SEC.

equity, optionsSEC
Mar 2012$22 MNo. 1$10 to $50 million

Cerecor Inc.: Raise no. 1, Mar 2012

Investors in this round

156 investors had bought by the notice of Apr 4, 2012: 156 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 10 investors are named for Cerecor Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $23 M offered; $0 M still to sell
Smallest investment taken
$24,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,207,919
Finders' fees
none
Paid to its own people
$1,074,960 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blake M. Paterson · Executive Officer, Director
  • Karen M. Krumeich · Executive Officer
  • Reza M. Mazhari · Executive Officer
  • Sharon M. Rowland · Executive Officer
  • Cary M. Sucoff · Director
  • Eugene M. Bauer · Director
  • Isaac M. Blech · Director
  • John M. Catsimatidis · Director
  • Sol M. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in AL, AZ, CA, CO, CT, DC, DE, FL, IL, IN, KS, KY, MA, MD, ME, MN, NJ, NV, NY, OH, OR, PA, PR, RI, TN, TX, VA, WA, WI

Signed by Blake M. Paterson, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 4, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cerecor Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2024

That is all the official record says: Cerecor Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Cerecor Inc. are on record.

Investors#

10 named in official filings. Open an investor to see everything it has backed.

Investors in Cerecor Inc.
InvestorKindAmountRoundRoleSource
Apple Tree Partners IV, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
ATP III GP, Ltd.Companynot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Isaac BlechPersonnot statednot statedHeld Series A preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
MPM Asset Management Investors BV5 LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
MPM Bioventures V GP LLCVenture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
MPM Bioventures V LLCVenture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
MPM Bioventures V, L.P.Venture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Nea 14 GP, LTDCompanynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
NEA Partners 14, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
New Enterprise Associates 14, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 156 investors.

Largest shareholders today

Institutions holding Avalo Therapeutics, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cerecor Inc.
NameRoleNamed in
Christopher SullivanExecutive officerApr 2024
Garry Neil, M.D.Executive officerApr 2024
John E KaiserExecutive officerMay 2017
Mariam E MorrisExecutive officerMay 2017
Ronald E MarcusExecutive officerMay 2017
Uli HacksellExecutive officerMay 2017
John KaiserExecutive officerSep 2016
Mariam MorrisExecutive officerSep 2016
Ronald MarcusExecutive officerSep 2016
Bernadine Heather FraserExecutive officerJul 2014
Blake M. PatersonExecutive officerJul 2014
Federica F. O'BrienExecutive officerJul 2014
James F. VornovExecutive officerJul 2014
John F. KaiserExecutive officerJul 2014
Reza F. MazhariExecutive officerJul 2014
Sharon F. RowlandExecutive officerJul 2014
Karen M. KrumeichExecutive officerApr 2012
Reza M. MazhariExecutive officerApr 2012
Sharon M. RowlandExecutive officerApr 2012
Aaron KantoffDirectorApr 2024
Garry Neil, M.D.DirectorApr 2024
Gilla Kaplan, Ph.D.DirectorApr 2024
Jonathan Goldman, M.D.DirectorApr 2024
June Almenoff, M.D., Ph.D.DirectorApr 2024
Magnus Persson, M.D., Ph.D.DirectorApr 2024
Mitchell ChanDirectorApr 2024
Samantha TruexDirectorApr 2024
Eugene A. BauerDirectorMay 2017
Isaac A. BlechDirectorMay 2017
Magnus E PerssonDirectorMay 2017
Phil E GutryDirectorMay 2017
Thomas E AasenDirectorMay 2017
Uli HacksellDirectorMay 2017
Behshad SheldonDirectorSep 2016
Eugene BauerDirectorSep 2016
Isaac BlechDirectorSep 2016
Magnus PerssonDirectorSep 2016
Phil GutryDirectorSep 2016
Thomas AasenDirectorSep 2016
Blake M. PatersonDirectorJul 2014

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.